EORTC protocol 08072 - 22074

Concurrent once-daily versus twice-daily radiotherapy : A 2-arm randomised controlled trial of concurrent chemo-radiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (SCLC) and good performance status (CONVERT).
Trial StatusOpen
DatesDate of activation: 23/09/2008
Data management at EORTC-
Phase3
Randomized trialYes
Type-
Targeted Sample sizeEORTC Groups: - - All Groups: 532
Number of steps1
Drug
Study StaffCorinne Faivre-Finn (Study Coordinator) - Christie Hospital, Manchester
Baktiar Hasan (Statistician) - EORTC, Brussels
Katrien Van Den Bossche (Data Manager) - EORTC, Brussels
Benedicte Marchal (Project Manager) - EORTC, Brussels, benedicte.marchal( at )eortc.be, +32 2 7741078
Type of cancerLung
Participating GroupsChristie's Hospital(Coordinating Group)
EORTC Lung Cancer Group
EORTC Radiation Oncology Group
Currently authorized centers
Protocol summaryLink provided by NCI PDQ
Back to Protocol section